The effects of yohimbine on the pharmacokinetic parameters of detomidine in the horse.

This research investigates the combined pharmacokinetic impact of two drugs, detomidine and yohimbine, on horses. The findings reveal that prior administration of detomidine affects yohimbine’s clearance and volume of distribution, suggesting potential consequences and warranting further investigation of these substances’ combined use.

Methodology

• The study was executed with the use of a randomized crossover design, ensuring that each participant went through all conditions of the experiment.
• The sample consisted of nine healthy adult horses approximately 9 years old and weighing around 561 kg.
• The experiment had three dosage regimens: detomidine alone, yohimbine alone, and a combination of detomidine followed by yohimbine 15 minutes later.
• A minimum of one week passed between each regimen to prevent carryover effects.
• After administration of the regimens, blood samples were taken from the horses to monitor the concentration levels of detomidine and yohimbine in the plasma. Liquid chromatography-mass spectrometry was used to analyze these samples.

Results

• Measured detomidine concentrations were 76.0 and 129.9 ng mL(-1) for the detomidine and detomidine-yohimbine treatments, respectively. Systemic clearance & volume of distribution for detomidine were not significantly different in either treatment.
• However, there was a considerable increase in the maximum measured yohimbine plasma concentrations from standalone yohimbine administration to the combined detomidine-yohimbine treatment.
• Clearance and volume of distribution for yohimbine were significantly less when given after detomidine compared to yohimbine-only treatment.
• After 18 hours, plasma concentrations for both substances fell below the quantifiable limit.

Conclusion

• The study concluded that the clearance and volume distribution of yohimbine were impacted by the prior administration of detomidine, although the elimination half-life of yohimbine remained unchanged.
• Increased plasma concentrations of yohimbine in the presence of detomidine carry the potential for unforeseen effects. This necessitates further studies to fully understand the physiological implications of using these two drugs in conjunction.